BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24187460)

  • 1. Antiviral therapy delays esophageal variceal bleeding in hepatitis B virus-related cirrhosis.
    Li CZ; Cheng LF; Li QS; Wang ZQ; Yan JH
    World J Gastroenterol; 2013 Oct; 19(40):6849-56. PubMed ID: 24187460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy.
    He L; Ye X; Ma J; Li P; Jiang Y; Hu J; Yang J; Zhou Y; Liang X; Lin Y; Wei H
    BMC Gastroenterol; 2019 Jun; 19(1):101. PubMed ID: 31226942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
    Lian JS; Zeng LY; Chen JY; Jia HY; Zhang YM; Xiang DR; Yu L; Hu JH; Lu YF; Zheng L; Li LJ; Yang YD
    World J Gastroenterol; 2013 Oct; 19(37):6278-83. PubMed ID: 24115827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis.
    Lv GC; Yao JM; Yang YD; Zheng L; Sheng JF; Chen Y; Li LJ
    World J Gastroenterol; 2013 Jun; 19(22):3481-6. PubMed ID: 23801842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of disease and survival after onset of decompensation in hepatitis B virus-related cirrhosis.
    Das K; Das K; Datta S; Pal S; Hembram JR; Dhali GK; Santra A; Chowdhury A
    Liver Int; 2010 Aug; 30(7):1033-42. PubMed ID: 20492502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.
    Xu Y; Zhang YG; Wang X; Qi WQ; Qin SY; Liu ZH; Jiao J; Wang JB
    World J Gastroenterol; 2015 Jul; 21(25):7869-76. PubMed ID: 26167087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C eradication with direct-acting anti-virals reduces the risk of variceal bleeding.
    Moon AM; Green PK; Rockey DC; Berry K; Ioannou GN
    Aliment Pharmacol Ther; 2020 Feb; 51(3):364-373. PubMed ID: 31773763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    Ye XG; Su QM
    World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
    Kim SU; Han KH; Nam CM; Park JY; Kim DY; Chon CY; Ahn SH
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1722-7. PubMed ID: 18717757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis.
    Abadía M; Montes ML; Ponce D; Froilán C; Romero M; Poza J; Hernández T; Fernández-Martos R; Olveira A;
    World J Gastroenterol; 2019 Jun; 25(21):2665-2674. PubMed ID: 31210717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
    Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
    Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
    Lampertico P; Invernizzi F; Viganò M; Loglio A; Mangia G; Facchetti F; Primignani M; Jovani M; Iavarone M; Fraquelli M; Casazza G; de Franchis R; Colombo M
    J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of portal vein thrombosis on the efficacy of endoscopic treatment in preventing re-bleeding from ruptured gastroesophageal varices in hepatitis B-related liver cirrhosis].
    Huang XQ; Ni LY; Jiang SY; Xia RQ; Ma LL; Wang J; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):747-752. PubMed ID: 33053974
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
    Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
    Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
    Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Yang X; Li J; Zhou L; Liu J; Wang J; Lu W
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):396-403. PubMed ID: 24569820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
    Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of change in esophageal varices and clinical characteristics in hepatitis B virus-related cirrhosis after antiviral therapy].
    Wang BQ; Wu XN; Zhou JL; Sun YM; Meng TT; Chen SY; Guan QS; He ZY; Wu SS; Kong YY; Ou XJ; Jia JD; You H
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):591-597. PubMed ID: 36038319
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.
    Eslam M; Ampuero J; Jover M; Abd-Elhalim H; Rincon D; Shatat M; Camacho I; Kamal A; Lo Iacono O; Nasr Z; Grande L; Banares R; Khattab MA; Romero-Gomez M
    Ann Hepatol; 2013; 12(4):588-98. PubMed ID: 23813137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.